You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 8 No. 6, Nov-Dec 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Topics
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Evidence-Based Medicine
 •Facial Plastic Surgery, Other
 •Randomized Controlled Trial
 •Prognosis/ Outcomes
 •Alert me on articles by topic

Treatment of Keloids and Hypertrophic Scars

A Meta-analysis and Review of the Literature

Douglas Leventhal, MD; Maxwell Furr, BS; David Reiter, MD, DMD

Arch Facial Plast Surg. 2006;8(6):362-368.

Management of hypertrophic scars and keloids has advanced from crude, invasive methods such as gross excision and radiation to intralesional or topical agents that act on a cellular level. There is no universally accepted treatment regimen and no evidence-based literature to guide management. Our objectives are to present a list of available treatment regimens, their proposed mechanisms of action, and supporting evidence and to perform a meta-analysis of clinical trials to identify treatments with a better-than-even likelihood of improvement. We conducted a PubMed search through October 2005, identifying clinical studies of various treatments for hypertrophic scars and keloids. We graded the quality of each study, delineated the results into favorable vs nonfavorable, and calculated the statistical significance of the findings. The meta-analysis of 70 treatment series for various clinical measures showed a 70% chance of improvement with treatment; however, the mean amount of improvement to be expected was around 60%. There was no statistically significant difference between treatments. Most treatments for keloidal and hypertrophic scarring offer minimal likelihood of improvement. The magnitude of likely permanent improvement in any sign or symptom may be clinically meaningful but far short of cure. Novel therapies deserve further investigation but remain without proven benefit to date.


Author Affiliations: Department of Otolaryngology—Head & Neck Surgery, Jefferson Medical College, and Center for Facial Plastic Surgery, Thomas Jefferson University Hospital, Philadelphia, Pa.


RELATED LETTER

Comparing Apples to Oranges in Meta-analysis Studies
John S. Rhee
Arch Facial Plast Surg. 2007;9(2):139-140.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparing Apples to Oranges in Meta-analysis Studies
Rhee
Arch Facial Plast Surg 2007;9:139-140.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.